Written question asked by Mark Tami (Labour) on Friday, 2 June 2023, in the House of Commons. It was due for an answer on Tuesday, 6 June 2023. It was answered by Will Quince (Conservative) on Tuesday, 13 June 2023 on behalf of the Department of Health and Social Care.
Advanced Therapy Medicinal Products: Health Professions
- Question
-
To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of introducing advanced therapy medicinal products-specific experts on National Institute for Health and Care Excellence single technology appraisal committees for the evaluation of new innovative advanced therapies.
- Answer
-
The Department has made no assessment. The National Institute for Health and Care Excellence is responsible for appointing members to its technology appraisal committees. Members reflect the spread of interests and expertise required for the business of the committee and are drawn from the National Health Service, patient and carer organisations, academia, and pharmaceutical and medical devices industries.
Additional experts may be invited to attend to advise the committee on a topic by topic basis to assist in considering and interpreting the evidence.
Secondary information
- Type
- Written question
- Reference
- 187053
- Session
- 2022-23
- Subjects
- Health professions National Institute for Health and Care Excellence Advanced therapy medicinal products
- Link
- View this Written question on www.parliament.uk
Librarians' tools
- Timestamp
- 2023-06-13 13:21:26 +0100
- URI
- http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/187053
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/187053
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/writtenparliamentaryquestion/commons/2022-23/187053